These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


188 related items for PubMed ID: 5576664

  • 1. The age related responses of New Zealand mice to a murine sarcoma virus.
    Gazdar AF, Beitzel W, Talal N.
    Clin Exp Immunol; 1971 Mar; 8(3):501-9. PubMed ID: 5576664
    [Abstract] [Full Text] [Related]

  • 2. Induction and regression of primary moloney sarcoma virus-induced tumors in mice.
    Fefer A, McCoy JL, Glynn JP.
    Cancer Res; 1967 Sep; 27(9):1626-31. PubMed ID: 4860892
    [No Abstract] [Full Text] [Related]

  • 3. Studies on immunity to autochthonous mouse tumors.
    Hellström I, Hellström KE, Pierce GE, Fefer A.
    Transplant Proc; 1969 Mar; 1(1):90-4. PubMed ID: 5406848
    [No Abstract] [Full Text] [Related]

  • 4. Increased oncogenicity of the murine sarcoma virus (Moloney) by co-infection with murine leukemia viruses.
    Chirigos MA, Perk K, Turner W, Burka B, Gomez M.
    Cancer Res; 1968 Jun; 28(6):1055-63. PubMed ID: 5658439
    [No Abstract] [Full Text] [Related]

  • 5. [Factors regulating the spontaneous regression of primary tumors induced by murine sarcoma virus, Moloney strain, in mice (BALB-c-Cb-Se). I. Age at treatment and virus doses].
    Ribacchi R, Giraldo G.
    Lav Ist Anat Istol Patol Univ Studi Perugia; 1967 Jun; 27(3):167-76. PubMed ID: 5605880
    [No Abstract] [Full Text] [Related]

  • 6. Quantitative dose-response relationships of murine sarcoma virus (Moloney) in BALB/c mice.
    Blumenschein GR, Moloney JB.
    J Natl Cancer Inst; 1969 Jan; 42(1):123-33. PubMed ID: 5765223
    [No Abstract] [Full Text] [Related]

  • 7. Detection of cellular immunity to murine sarcoma virus-induced tumors by leukocyte adherence inhibition.
    Mortensen RF.
    J Natl Cancer Inst; 1979 Jan; 62(1):157-63. PubMed ID: 214608
    [No Abstract] [Full Text] [Related]

  • 8. Effect of cortisone on oncogenesis by murine sarcoma virus (Moloney).
    Shachat DA, Fefer A, Moloney JB.
    Cancer Res; 1968 Mar; 28(3):517-20. PubMed ID: 4867925
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Blocking effect of serum from tumor-bearing animals on macrophage migration inhibition with tumor antigens.
    Halliday WJ.
    J Immunol; 1971 Mar; 106(3):855-7. PubMed ID: 5547301
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Some biologic, immunogenic, and morphologic effects in mice after infection with a murine sarcoma virus. I. Biologic and immunogenic studies.
    Law LW, Ting RC, Stanton MF.
    J Natl Cancer Inst; 1968 May; 40(5):1101-12. PubMed ID: 5648135
    [No Abstract] [Full Text] [Related]

  • 19. Immunological and pathological manifestations of murine sarcoma virus (Moloney) infections.
    Schlom J, Moloney JB, Groupé V.
    Cancer Res; 1970 Dec; 30(12):2955-61. PubMed ID: 5494580
    [No Abstract] [Full Text] [Related]

  • 20. Tumour regression and relapse in mice inoculated with murine sarcoma virus (Moloney).
    Perk K, Russell E, Smith KL, Moloney JB.
    Lab Anim; 1973 Sep; 7(3):255-63. PubMed ID: 4795193
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.